A Double-inactivated Whole Virus Candidate Sars Coronavirus Vaccine Stimulates Neutralising and Protective Antibody Responses.
From: Baxter Vaccines, Biomedical Research Centre, Uferstr. 15, 2304 Orth/Donau, Austria. martin.spruth@baxter.com
Vaccine
- Publish Date: Jan 2006
- ISSN: 0264-410X
- Volume: 24
- Issue: 5
- Pages: 652-61
- Medium: Print
- Language: English
- Citation (JAMA): Spruth Martin, Kistner Otfried, Savidis-Dacho Helga, et al. A Double-inactivated Whole Virus Candidate Sars Coronavirus Vaccine Stimulates Neutralising and Protective Antibody Responses.. Vaccine Jan 2006;24:652-61
Abstract
A double-inactivated, candidate whole virus vaccine against severe acute respiratory syndrome associated coronavirus (SARS-CoV) was developed and manufactured at large scale using fermenter cultures of serum protein free Vero cells. A two step inactivation procedure involving sequential formaldehyde and U.V. inactivation was utilised in order to ensure an extremely high safety margin with respect to residual infectivity. The immunogenicity of this double-inactivated vaccine was characterised in the mouse model. Mice that were immunised twice with the candidate SARS-CoV vaccine developed high antibody titres against the SARS-CoV spike protein and high levels of neutralising antibodies. The use of the adjuvant Al(OH)3 had only a minor effect on the immunogenicity of the vaccine. In addition, cell mediated immunity as measured by interferon-gamma and interleukin-4 stimulation, was elicited by vaccination. Moreover, the vaccine confers protective immunity as demonstrated by prevention of SARS-CoV replication in the respiratory tract of mice after intranasal challenge with SARS-CoV. Protection of mice was correlated to antibody titre against the SARS-CoV S protein and neutralising antibody titre.
Mesh Headings (Keywords): Adjuvants, Immunologic, Animals, Antibodies, Viral, Blotting, Western, Cercopithecus aethiops, Dose-Response Relationship, Immunologic, Electrophoresis, Polyacrylamide Gel, Enzyme-Linked Immunosorbent Assay, Female, Fermentation, Immunization, Mice, Mice, Inbred BALB C, Neutralization Tests, SARS Virus, Severe Acute Respiratory Syndrome, Tissue Culture Techniques, Vaccines, Inactivated, Vero Cells, Viral Vaccines
Check for Full Text / PubMed Unique Identifier (PMID): 16214268
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.